July 16, 2024
1 min read

Long-Term Heart Risks Vital in Hypertension Treatment

PREVENT uses sex-specific equations; incorporates markers of kidney disease in addition to HbA1c measures to help monitor metabolic health; can estimate 10-year and 30-year risk for heart attack or stroke as well as heart failure; and considers additional risk factors with the social deprivation index…reports Asian Lite News

Doctors must consider the long-term (30-year) as well as the short-term (10-year) risk of an individual developing cardiovascular disease (CVD) before beginning medication therapy for stage 1 hypertension, or high blood pressure, according to new research on Monday by the American Heart Association (AHA). 

The research, published in the AHA’s journal Hypertension, made a comparison of two tools for calculating cardiovascular disease risks.

It showed that “if only the current 10-year risk thresholds are applied, fewer adults may be recommended for blood pressure-lowering medication.”

The team from the University of Alabama compared the predicted risks estimated by the AHA’s PREVENT risk calculator, released in 2023, to the previous tool for risk prediction called the Pooled Cohort Equations (PCE).

PREVENT uses sex-specific equations; incorporates markers of kidney disease in addition to HbA1c measures to help monitor metabolic health; can estimate 10-year and 30-year risk for heart attack or stroke as well as heart failure; and considers additional risk factors with the social deprivation index.

On the other hand, the PCE does not calculate 30-year risk and also does not include heart failure or additional risk factor predictors such as kidney function or statin use.

“Many people with stage 1 high blood pressure who are not likely to have a heart attack, stroke, or heart failure within the next 10 years may have a high risk over the next 30 years,” said lead author Paul Muntner, a visiting professor in the department of epidemiology at the University.

This may also benefit people with no risk or short-term risk and “start anti-hypertensive medication” to prevent a heart attack or stroke event later in life.

ALSO READ-Healthcare Leaders Urge Infra Investment, Tax Reforms in Union Budget

Previous Story

DIPA Calls for Policies to Boost Digital Infra

Next Story

Rasika Dugal Praises OTT for Fostering New Talent

Latest from Health

Deadly Fever Grips Senegal

Currently, there is no vaccine or antiviral treatment approved for human use against RVF. Senegal is facing a growing public health emergency as the death toll from a Rift Valley Fever (RVF)

Generic Drugs Boost Hypertension Control

By setting price ceilings on essential medicines based on average market prices, India successfully kept out-of-pocket costs low while still ensuring manufacturers made sustainable profits India’s focused public health strategies—centered on generic

Millions of vaccines to be made in Oxfordshire

State-of-the-art research centre promises millions of seasonal vaccines, pandemic preparedness, and a boost to Britain’s £100bn life sciences sector…reports Asian Lite News A new era of vaccine innovation has begun in Oxfordshire

Physiotherapy in Healthy Ageing

This year’s theme, “Healthy Ageing – Role of Physiotherapy in Falls and Frailty”, draws attention to the significance of physiotherapy in preventing falls, managing frailty, and supporting dignified ageing among the elderly

Lower BP Target Could Benefit Indians

Beyond salt reduction, experts stressed that controlling hypertension requires a comprehensive approach. Regular exercise, maintaining a healthy body weight, reducing alcohol intake, quitting tobacco, and consuming a balanced diet rich in fruits
Go toTop

Don't Miss

Excessive screen time may raise risk of early puberty

The findings linked the early risk of puberty with accelerated

Health balancing amid hustle-bustle of work-life

With the breakfast market evolving every year as per the